SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-012390
Filing Date
2020-02-07
Accepted
2020-02-07 12:58:14
Documents
1
Period of Report
2019-12-19

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4908
  Complete submission text file 0001104659-20-012390.txt   7402
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Reporting) CIK: 0000901832 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35112 | Film No.: 20586369
SIC: 2834 Pharmaceutical Preparations

Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Issuer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MILSTEIN BUILDING, GRANTA PARK CAMBRIDGE X0 CB21 6GH
Business Address MILSTEIN BUILDING, GRANTA PARK CAMBRIDGE X0 CB21 6GH 44 1223 471471
MedImmune Ltd (Reporting) CIK: 0001790714 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35112 | Film No.: 20586370